| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 102.018 | 76 |
| GSM780708 | Untreated after 4 days (C2_1) | 89.9253 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 94.6958 | 74 |
| GSM780719 | Untreated after 4 days (C1_2) | 89.6784 | 74 |
| GSM780720 | Untreated after 4 days (C2_2) | 113.136 | 77 |
| GSM780721 | Untreated after 4 days (C3_2) | 90.8219 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 101.239 | 75 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 98.7895 | 75 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 99.8449 | 75 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 97.332 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 107.993 | 76 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 106.692 | 76 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 82.1369 | 72 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 94.5459 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 89.0163 | 73 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 90.1391 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 90.8329 | 74 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 106.928 | 76 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 114.038 | 77 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 96.4116 | 75 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 84.9686 | 73 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 114.716 | 77 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 90.2008 | 74 |